(NYSE: DGX) Quest Diagnostics's forecast annual revenue growth rate of 3.91% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.59%.
Quest Diagnostics's revenue in 2026 is $11,841,000,000.On average, 20 Wall Street analysts forecast DGX's revenue for 2026 to be $1,342,452,728,746, with the lowest DGX revenue forecast at $1,293,824,298,480, and the highest DGX revenue forecast at $1,397,902,341,538. On average, 20 Wall Street analysts forecast DGX's revenue for 2027 to be $1,402,633,161,677, with the lowest DGX revenue forecast at $1,347,403,587,031, and the highest DGX revenue forecast at $1,485,257,485,500.
In 2028, DGX is forecast to generate $1,461,493,365,732 in revenue, with the lowest revenue forecast at $1,395,261,883,786 and the highest revenue forecast at $1,548,298,414,329.